Lophos Pharmaceuticals

Lophos Pharmaceuticals is a Canadian bioscience company focused on the cultivation, research, and development of mescaline-producing cacti, specifically Lophophora williamsii (peyote). The company aims to establish a sustainable and scalable supply chain for natural mescaline to support the emerging psychedelic therapy market. Through its subsidiary, Lophos Pharma Corp, it holds a Health Canada Controlled Substances Dealer's License, which permits the legal possession, production, and sale of mescaline for research purposes. Lophos is dedicated to developing standardized natural psychedelic products for the treatment of mental health conditions such as PTSD and depression. Their business model combines advanced controlled-environment agriculture with pharmaceutical-grade extraction and formulation.